Back

Prognostic value of coronary flow velocity reserve in obese patients with preserved ejection fraction and negative stress echocardiography

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Echocardiography in coronary artery disease Stress Echocardiography ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Quirino Ciampi

Fatebenefratelli Hospital of Benevento, Benevento (Italy)

6 More presentations in this session

Presentation thumbnail
Prediabetes in ST-elevation myocardial infarction patients: implications for left ventricular function one year post-infarction
Doctor L. Caunite (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Advanced echocardiographic analysis in identifying significant coronary artery disease
Ms P. Suri (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Transient ST-segment elevation during stress echocardiography: coronary anatomic, functional, and prognostic correlates
Doctor N. Carabetta (Catanzaro, IT)
Abstract Slides Video
Presentation thumbnail
Association of Left Ventricular Contractile Reserve (LVCR) and coronary artery disease in patients undergoing stress echocardiography
Doctor K. Hemedez (Metro Manila, PH)
Abstract Slides Video
Presentation thumbnail
Positivity of stress echocardiography is getting more benign over time: a 20-year analysis
Mrs L. Balkeviciene (Vilnius, LT)
Abstract Slides Video

Access the full session

Session thumbnail
Echocardiography in coronary artery disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Long-term prognostic value of myocardial work analysis across obesity stages: insights from a community-based study
thumbnail
Congress Presentation
Is the obesity paradox leading to a less stringent secondary prevention strategy in post-acute coronary syndrome patients?
thumbnail
Congress Presentation
Independent prognostic value of ejection fraction, resting coronary flow, coronary flow reserve, myocardial viability, and inducible ischemia in heart failure with a reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources